[Federal Register Volume 70, Number 191 (Tuesday, October 4, 2005)]
[Notices]
[Pages 57878-57879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-19827]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-05-05CZ]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-371-5983 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to <a href="/cdn-cgi/l/email-protection#bfd0d2ddffdcdbdc91d8d0c9"><span class="__cf_email__" data-cfemail="90fffdf2d0f3f4f3bef7ffe6">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Assessing Diabetes Detection Initiative for Policy Decisions--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Type 2 diabetes is a chronic disease that affects more than 18 
million Americans, approximately 5 million of whom do not know that 
they have the disease. As the disease progresses, it often causes 
severe complications, including heart disease, blindness, lower 
extremity arterial disease, and kidney failure. Native Americans, 
African Americans, Latino Americans, and some Asian Americans and 
Pacific Islanders are disproportionately affected by diabetes. 
Identifying persons who have undiagnosed diabetes and treating them 
could prevent or delay diabetes complications.
    In November 2003 the Diabetes Detection Initiative (DDI) was 
launched in 10 pilot sites around the U.S. to identify a portion of the 
estimated 5 million people with undiagnosed Type 2 diabetes, targeting 
specific areas in each of 10 locales in which residents are likely to 
be at higher risk for Type 2 diabetes. Implementation of the DDI 
involved distributing a paper-and-pencil risk test. Individuals whose 
score indicated that they were at an increased risk for diabetes were 
advised to see their regular doctor (or to schedule an appointment at 
one of several clinics that had agreed to participate in the DDI) to 
receive a finger-stick or other tests to confirm whether or not they 
have diabetes. Whether or not the DDI should be expanded to other 
communities depends on the health benefits and costs of the program. 
The CDC is planning to conduct a study to provide this critical 
information.
    The planned study will assess the resources used, the cost per case 
detected, and the perceived benefit of the DDI to participants. Data 
for the economic assessment will be obtained by conducting surveys of 
local DDI implementation teams, leadership at participating health 
clinics, and patients at participating health clinics. The results of 
the study will also provide information needed for conducting a more 
complete cost-effectiveness analysis of screening for undiagnosed 
diabetes.
    The point-of-contact (Implementation team member) in each of the 10 
regions will be sent a mail survey to collect information regarding the 
staff time and other resources used to implement the DDI program 
(including the staff time and resources used by community-based 
organizations that participated in the DDI implementation). These 
planning and implementation activities include participating in 
meetings and conference calls, recruiting clinics and community-based 
organizations to participate in the DDI, distributing risk tests, 
organizing health fairs and other community events, and designing media 
campaigns to promote the DDI.
    The health clinic leadership survey will be mailed to one person at 
each of the 43 clinics that participated in the DDI implementation. The 
survey will collect information regarding the costs associated with the 
clinic's participation in the DDI. These will include the medical costs 
of providing care to patients who visited the clinic as a result of the 
DDI, staff time associated with DDI planning and implementation,

[[Page 57879]]

and any staff time that was devoted to performing finger stick tests at 
locations other than the health clinic (e.g., health fairs, shopping 
malls, work sites, housing complexes). Of the 43 clinics to be 
surveyed, we expect that 30 (70%) will complete the survey.
    A computer-assisted in-person interview will be administered to 600 
clinic patients--60 in each of the 10 regions in which the pilot DDI 
was implemented. The survey will collect background information, out-
of-pocket medical and non-medical direct health care costs (e.g., co-
payments, transportation costs, value of patients' time associated with 
the clinic visit), and preferred features of a diabetes screening 
program. There are no costs to respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                   Respondents                       Number of     responses per   per  response   Total burden
                                                    respondents     respondent      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Implementation team members.....................              10               1               2              20
Clinic staff....................................              30               1               1              30
Patients at DDI clinics.........................             600               1           20/60             200
                                                 -----------------
    Total.......................................             640  ..............  ..............             250
----------------------------------------------------------------------------------------------------------------


    Dated: September 27, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 05-19827 Filed 10-3-05; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>